Who are DSS, Inc.'s main suppliers?

DSS, Inc. (DSS) key suppliers include: AEGIS-CAPITAL-CORP, ALSET-INTERNATIONAL-LIMITED, ONE-VENDOR, Impact BioMedical Inc., Impact BioMedical Inc.. View the full supplier network at chainsifter.com/chain/DSS.

Who are DSS, Inc.'s major customers?

DSS, Inc. (DSS) key customers include: FIVE-CUSTOMERS, ONE-CUSTOMER, TWO-CUSTOMERS, PREMIER-PACKAGING-CORPORATION, Impact BioMedical Inc. and 1 more. View the full customer network at chainsifter.com/chain/DSS.

What sector is DSS, Inc. in?

DSS, Inc. (DSS) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

DSS Supply Chain: DSS, Inc. Supplier List & 14 Relationships

5Suppliers

6Customers

3Debt Items

3Related Chains

DSS, Inc. Suppliers

Ticker	Name	Confidence	Evidence
AEGIS-CAPITAL-CORP	AEGIS-CAPITAL-CORP	92%	On February 4, 2026, DSS, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp. ("Aegis"), which provided for the issuance and sale by th…
ALSET-INTERNATIONAL-LIMITED	ALSET-INTERNATIONAL-LIMITED	92%	Alset International Limited will loan the Company $2,450,000, in exchange for a convertible promissory note and warrant to purchase 16,554,055 shares of the Company's common stock
ONE-VENDOR	ONE-VENDOR	90%	As of March 31, 2026 and 2025 one vendor accounted for approximately 13 % and 11 %, respectively, of our cost of revenue
IBO	Impact BioMedical Inc.	72%	Reciprocal relationship from IBO graph: Reciprocal relationship from DSS graph: ating segments in 2024 highlight the company’s ongoing commitment to innovation and diversification. Each segment is st…
IBO	Impact BioMedical Inc.	72%	ating segments in 2024 highlight the company’s ongoing commitment to innovation and diversification. Each segment is strategically positioned for growth, with Premier Packaging and Commercial Lending…

DSS, Inc. Customers

Ticker	Name	Confidence	Evidence
FIVE-CUSTOMERS	FIVE-CUSTOMERS	92%	As of December 31, 2025, five customers accounted for 19%, 18%, 13%, 12% and 11% of our trade accounts receivable balance.
ONE-CUSTOMER	ONE-CUSTOMER	92%	As of December 31, 2025, one customers accounted for approximately 29% of our consolidated revenue.
TWO-CUSTOMERS	TWO-CUSTOMERS	92%	As of December 31, 2024, two customers accounted for approximately 22% and 13% of our consolidated revenue
PREMIER-PACKAGING-CORPORATION	PREMIER-PACKAGING-CORPORATION	85%	ght the Company’s ongoing commitment to innovation and diversification. Each segment is strategically positioned for growth, with Premier Packaging and Commercial Lending continuing to evolve and ada…
IBO	Impact BioMedical Inc.	72%	Reciprocal relationship from IBO graph: Reciprocal relationship from DSS graph: Reciprocal relationship from IBO graph: Reciprocal relationship from DSS graph: ating segments in 2024 highlight the co…
IBO	Impact BioMedical Inc.	72%	ating segments in 2024 highlight the company’s ongoing commitment to innovation and diversification. Each segment is strategically positioned for growth, with Premier Packaging and Commercial Lending…

DSS, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
DSS-DEBT-9153	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2019-12-31.
DSS-DEBT	Debt stack $43.1M	90%	Market cache reports total debt of $43.1M.
DSS-DEBT-9152	Warrants outstanding: 333333	90%	xbrl warrant detail from xbrl 2020-12-31.

DSS, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for DSS, Inc..

DSS, Inc. Ownership

Holder	Name	Confidence	Evidence
DSS-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 17 tracked holders.

DSS, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
IBO	Impact BioMedical Inc.	100.00	1	['customer', 'supplier']
PRPH	ProPhase Labs, Inc.	50.00	2
CHEMIA	CHEMIA	50.00	2

DSS, Inc. Supply Chain